| ORIGINAL ARTICLE |
|
| Year : 2015 | Volume
: 30
| Issue : 3 | Page : 199-203 |
|
|
The role of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with mycosis fungoides
Eiman Alanteri1, Sharjeel Usmani1, Fahad Marafi1, Abulredha Esmail1, Abdullah Ali2, Rehab S Elhagracy3, Salem Alshemmari4
1 Department of Nuclear Medicine, Kuwait Cancer Control Center, Kuwait City, Kuwait
2 Department of Pathology, Kuwait Cancer Control Center, Kuwait City, Kuwait
3 Department of Medical Oncology, Kuwait Cancer Control Center, Kuwait City, Kuwait
4 Department of Medicine, Kuwait University, Kuwait City, Kuwait
Correspondence Address:
Sharjeel Usmani
Department of Nuclear Medicine, Kuwait Cancer Control Center, Kuwait City
Kuwait
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-3919.158527
|
|
|
Purpose: The aim of the present study is to evaluate the possible role of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography ( 18 F-FDG PET-CT) in the management of mycosis fungoides (MF). Materials and Methods: Nineteen patients (mean age, 40.6 years; median age 41 years; 16 males and 3 females) with risk of secondary lymph node (LN) involvement (those with large cell transformation, tumors, erythroderma, or enlarged LNs on physical examination) were included in the study. All patients underwent PET-CT scan by injecting 0.06 mCi/kg of F18 FDG. The maximum standard uptake value (SUVmax) was recorded for each patient. Results: The 18 F-FDG PET-CT was positive in 15 patients. PET-CT detected local cutaneous disease in 13 cases. The range of SUVmax is 2.8-14.1. Out of 19 patients, hypermetabolic adenopathy is found in 9 patients and visceral involvement in one. Conclusions: Although the study population is small our findings suggests that 18 F-FDG PET-CT can detect cutaneous and extracutaneous lesions in MF and may guide biopsies especially in patients with risk of secondary LN involvement. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
